Breast cancers with a lot of TLSs also have more CD8+ T cells, which often take on tissue-resident or stem-like phenotypes, and a gene expression profile that favors a type 1 CD4+ helper T cell (Th1)/cytotoxic immune response [32]. This evidence concerns the gene CD4 and breast carcinoma.